SCHEMBL19852461

SCHEMBL19852461

CC1(I)CCCCNCC1

nearest known ligand 0.48

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.38
CXCR4 P61073 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18899078 0.98 ALDH1A1 (0.43) ALDH1A1CXCR4SMN1; SMN2
SCHEMBL21142461 0.92 ALDH1A1 (0.47) ALDH1A1CXCR4SMN1; SMN2
SCHEMBL21142462 0.92 ALDH1A1 (0.47) ALDH1A1CXCR4SMN1; SMN2
SCHEMBL25685247 0.92 ALDH1A1 (0.47) ALDH1A1CXCR4SMN1; SMN2
SCHEMBL18664102 0.87
SCHEMBL4237103 0.78
SCHEMBL18373104 0.74
SCHEMBL172691 0.74
SCHEMBL13195668 0.74
SCHEMBL13609726 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018026371-A1 DUAL NAV1.2/5HT2A INHIBITORS FOR TREATING CNS DISORDERS SUNOVION PHARMACEUTICALS INC. (US) 2018-02-08 WO disclosed